Publications

Cartmell, Christopher, et al. “Synthetic Analogues of Cyanobacterial Alkaloid Cylindrospermopsin and Their Toxicological Activity.”. Toxicol In Vitro, vol. 44, Oct. 2017, pp. 172-81, https://doi.org/10.1016/j.tiv.2017.07.007.

Grenald, Shaness A, et al. “Targeting the S1P S1PR1 Axis Mitigates Cancer-Induced Bone Pain and Neuroinflammation.”. Pain, vol. 158, no. 9, Sept. 2017, pp. 1733-42, https://doi.org/10.1097/j.pain.0000000000000965.

Nelson, Michele A, et al. “Anti-NMDA Receptor Encephalitis Presenting As a Primary Psychotic Disorder”. Ann Clin Psychiatry, vol. 29, no. 3, Aug. 2017, pp. 205-6.

Abdullahi, Wazir, et al. “Bone Morphogenetic Protein-9 Increases the Functional Expression of Organic Anion Transporting Polypeptide 1a4 at the Blood-Brain Barrier via the Activin Receptor-Like Kinase-1 Receptor.”. J Cereb Blood Flow Metab, vol. 37, no. 7, July 2017, pp. 2340-5, https://doi.org/10.1177/0271678X17702916.

Abdullahi, Wazir, et al. “Functional Expression of P-Glycoprotein and Organic Anion Transporting Polypeptides at the Blood-Brain Barrier: Understanding Transport Mechanisms for Improved CNS Drug Delivery?”. AAPS J, vol. 19, no. 4, July 2017, pp. 931-9, https://doi.org/10.1208/s12248-017-0081-9.

Lochhead, Jeffrey J, et al. “Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.”. AAPS J, vol. 19, no. 4, July 2017, pp. 910-2, https://doi.org/10.1208/s12248-017-0076-6.

Xie, Jennifer Y, et al. “Kappa Opioid Receptor Antagonists: A Possible New Class of Therapeutics for Migraine Prevention.”. Cephalalgia, vol. 37, no. 8, July 2017, pp. 780-94, https://doi.org/10.1177/0333102417702120.

Stefanucci, Azzurra, et al. “Fluorescent-Labeled Bioconjugates of the Opioid Peptides Biphalin and DPDPE Incorporating Fluorescein-Maleimide Linkers.”. Future Med Chem, vol. 9, no. 9, June 2017, pp. 859-6, https://doi.org/10.4155/fmc-2016-0232.

Grenald, Shaness A, et al. “Synergistic Attenuation of Chronic Pain Using Mu Opioid and Cannabinoid Receptor 2 Agonists.”. Neuropharmacology, vol. 116, Apr. 2017, pp. 59-70, https://doi.org/10.1016/j.neuropharm.2016.12.008.

Wheeler, Sarah E, and Lee, Nam Y. “Emerging Roles of Transforming Growth Factor β Signaling in Diabetic Retinopathy.”. J Cell Physiol, vol. 232, no. 3, Mar. 2017, pp. 486-9, https://doi.org/10.1002/jcp.25506.

Olson, Keith M, et al. “Novel Molecular Strategies and Targets for Opioid Drug Discovery for the Treatment of Chronic Pain.”. Yale J Biol Med, vol. 90, no. 1, Mar. 2017, pp. 97-110.

Ibrahim, Mohab M, et al. “Long-Lasting Antinociceptive Effects of Green Light in Acute and Chronic Pain in Rats.”. Pain, vol. 158, no. 2, Feb. 2017, pp. 347-60, https://doi.org/10.1097/j.pain.0000000000000767.

Watts, George S, et al. “16S RRNA Gene Sequencing on a Benchtop Sequencer: Accuracy for Identification of Clinically Important Bacteria.”. J Appl Microbiol, Jan. 2017, https://doi.org/10.1111/jam.13590.

Starnowska, Joanna, et al. “Analgesic Properties of Opioid NK1 Multitarget Ligands With Distinct in Vitro Profiles in Naive and Chronic Constriction Injury Mice.”. ACS Chem Neurosci, Jan. 2017, https://doi.org/10.1021/acschemneuro.7b00226.

Pan, Christopher C, et al. “Angiostatic Actions of Capsicodendrin through Selective Inhibition of VEGFR2-Mediated AKT Signaling and Disregulated Autophagy.”. Oncotarget, vol. 8, no. 8, Jan. 2017, pp. 12675-8, https://doi.org/10.18632/oncotarget.9307.

Moutal, A, et al. “Blocking CRMP2 SUMOylation Reverses Neuropathic Pain”. Mol Psychiatry, Jan. 2017, https://doi.org/10.1038/mp.2017.117.

Yin, Fei, et al. “Editorial: The Metabolic-Inflammatory Axis in Brain Aging and Neurodegeneration”. Front Aging Neurosci, vol. 9, Jan. 2017, p. 209, https://doi.org/10.3389/fnagi.2017.00209.

Geifman, Nophar, et al. “Evidence for Benefit of Statins to Modify Cognitive Decline and Risk in Alzheimer’s Disease.”. Alzheimers Res Ther, vol. 9, no. 1, Jan. 2017, p. 10, https://doi.org/10.1186/s13195-017-0237-y.

Sandweiss, A J, et al. “Genetic and Pharmacological Antagonism of NK1 Receptor Prevents Opiate Abuse Potential.”. Mol Psychiatry, Jan. 2017, https://doi.org/10.1038/mp.2017.102.

Lei, Wei, et al. “Heat-Shock Protein 90 (Hsp90) Promotes Opioid-Induced Anti-Nociception by an ERK Mitogen-Activated Protein Kinase (MAPK) Mechanism in Mouse Brain.”. J Biol Chem, vol. 292, no. 25, Jan. 2017, pp. 10414-28, https://doi.org/10.1074/jbc.M116.769489.

Moutal, Aubin, et al. “Homology-Guided Mutational Analysis Reveals the Functional Requirements for Antinociceptive Specificity of Collapsin Response Mediator Protein 2-Derived Peptides.”. Br J Pharmacol, Jan. 2017, https://doi.org/10.1111/bph.13737.

Ibbotson, Kathryn, et al. “Nrf2 Signaling Increases Expression of ATP-Binding Cassette Subfamily C MRNA Transcripts at the Blood-Brain Barrier Following Hypoxia-Reoxygenation Stress.”. Fluids Barriers CNS, vol. 14, no. 1, Jan. 2017, p. 6, https://doi.org/10.1186/s12987-017-0055-4.

Wang, J Y, et al. “Open-Label Allopregnanolone Treatment of Men With Fragile X-Associated Tremor Ataxia Syndrome.”. Neurotherapeutics, Jan. 2017, https://doi.org/10.1007/s13311-017-0555-6.

Hernandez, Gerson, et al. “Pharmacokinetics and Safety Profile of Single-Dose Administration of an Estrogen Receptor β-Selective Phytoestrogenic (phytoSERM) Formulation in Perimenopausal and Postmenopausal Women.”. Menopause, Jan. 2017, https://doi.org/10.1097/GME.0000000000000984.

Remesic, Michael, et al. “Recent Advances in the Realm of Allosteric Modulators for Opioid Receptors for Future Therapeutics.”. ACS Chem Neurosci, vol. 8, no. 6, Jan. 2017, pp. 1147-58, https://doi.org/10.1021/acschemneuro.7b00090.